Gn-RH antagonist possible response, after Gn-RH Agonist failure in a man with metastatic prostate cancer
Articolo
Data di Pubblicazione:
2005
Citazione:
Gn-RH antagonist possible response, after Gn-RH Agonist failure in a man with metastatic prostate cancer / B. Rocco, M. Ferrari, E. Scardino, D.V. Matei, F. Verweij, R. Varela, O. De Cobelli. - In: ANTICANCER RESEARCH. - ISSN 0250-7005. - 25:1B(2005 Jan), pp. 577-578.
Abstract:
Gn-RH agonists or surgical castration are considered standard treatment for patients affected by metastatic prostate cancer. Despite greater cost, chemical castration is often considered the treatment of choice as it is psychologically better tolerated. We report our experience of one patient undergoing treatment with Gn-RH agonist who developed an early resistance to the administered drug, with serum testosterone levels within the range of normality.
Tipologia IRIS:
01 - Articolo su periodico
Keywords:
Drug resistance; Gn-RH agonist; Leuprorelin; Prostate cancer; Triptorelin
Elenco autori:
B. Rocco, M. Ferrari, E. Scardino, D.V. Matei, F. Verweij, R. Varela, O. De Cobelli
Link alla scheda completa:
Link al Full Text: